TPD52 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of TPD52 Antibodies for research focused on understanding TPD52 protein functions. TPD52 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).TPD52, or Tumor Protein D52, plays essential roles in cell proliferation, differentiation, and apoptosis. TPD52 expression patterns show significant correlations with various cancer types, making it a crucial target for oncology research. Understanding TPD52 mechanisms can reveal new insights into tumor development and potential treatment approaches.Researchers worldwide utilize TPD52 monoclonal antibodies to investigate cellular signaling pathways and molecular interactions. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of TPD52 in experimental settings.Current studies highlight TPD52's involvement in cell cycle regulation and its potential as a biomarker. Ongoing research continues to uncover new aspects of TPD52 biology and its impact on disease progression.Santa Cruz Biotechnology monoclonal antibodies for TPD52 research support scientists in advancing our understanding of cancer biology and developing innovative therapeutic strategies.